AJ
Insider selling
Andrew J Murphy sold $3.2M of Regeneron Pharmaceuticals, Inc. (REGN) stock
Andrew J Murphy, Co-Chief Scientific Officer of Regeneron Pharmaceuticals, Inc. (REGN), sold 4,147 shares of REGN stock worth $3.2M, per an SEC Form 4 filed Oct 15, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 13, 2026, 2 days before it was made public.
REGN has moved +3.4% since the trade date, from $753.12 to $778.36 (Oct 14, 2026 close).
- Traded
- Oct 13, 2026
- Disclosed
- Oct 15, 2026
- Filing delay
- 2 days
- Price since
- +3.4%
- Role
- Co-Chief Scientific Officer
- Source
- SEC Form 4
More REGN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.